ビリルビン測定器の世界市場：2024年～2031年

概要

ビリルビン測定器の世界市場は、2023年に1億810万米ドルに達し、2031年には1億3,640万米ドルに達すると予測され、予測期間2024年～2031年のCAGRは10.16%で成長すると予測されています。

ビリルビン測定器は、患者の血液中のビリルビン量を測定する装置です。新生児黄疸の診断と治療において重要なツールです。通常、分光光度法を用いてビリルビン濃度を測定し、黄疸、肝疾患、溶血性疾患などの病気の診断やモニタリングに役立ちます。

ビリルビン測定器は、携帯用と検査室用の両方にあり、臨床的な意思決定に不可欠なデータを提供します。新生児では黄疸の評価、重症度の判定、光線療法などの治療の必要性の判定によく使用されます。ビリルビン代謝の評価と分析に役立ち、肝炎、肝硬変、その他の代謝性疾患などの肝疾患の診断に役立ちます。

市場力学：

促進要因と阻害要因

ビリルビン測定器の技術進歩

ビリルビン測定器の技術的進歩は、市場の成長を促進すると予想されます。強化された分光光度法や多波長分析などの測定技術は、より一貫性のある結果をもたらし、これらの機器への信頼を高めています。光センサーを利用して皮膚からビリルビン濃度をモニターする非侵襲性ビリルビン測定器は、特に乳幼児にとってスクリーニングの快適性と利用しやすさを向上させると期待されています。

小型化とユーザーインターフェースデザインの進歩により、医療従事者が最小限の指導で操作できる、より携帯可能で使いやすい機器が開発され、広く使用されるようになった。分析時間の短縮は、臨床環境におけるワークフローの効率を改善し、迅速な診断と治療の決定を可能にします。技術の進歩は製造コストの低下をもたらし、ビリルビン測定器をヘルスケア施設にとって安価なものとし、市場シェアを押し上げます。したがって、上記の要因が市場の成長を促進すると予想されます。

機器の高コスト

特に低・中所得地域の病院や診療所では、高価な機器への資金援助が必要な場合があります。そのため、新技術への投資能力が制限され、導入が阻害される可能性があります。より安価な選択肢が存在すれば、将来の購入者はそちらを選ぶかもしれず、高価格製品の競争は難しくなります。その結果、プレミアム製品の市場シェアが低下する可能性があります。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • ビリルビン測定器の技術進歩
  • 抑制要因
    • 装置の高コスト
  • 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析
• 償還分析
• 特許分析
• SWOT分析
• DMIオピニオン

第6章 製品タイプ別

• ベンチトップ型
• 経皮性

第7章 年齢層別

• 新生児
• 成人
• その他

第8章 適応症別

• 肝炎
• 黄疸
• その他

第9章 エンドユーザー別

• 病院
• 診療所
• 診断センター
• その他

第10章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• 中東・アフリカ

第11章 競合情勢

• 競合シナリオ
• 市況/シェア分析
• M&A分析

第12章 企業プロファイル

• Delta Medical International Ltd
  • 会社概要
  • 製品ポートフォリオと説明
  • 財務概要
  • 主な発展
• Mennen Medical Ltd
• Ningbo David Medical Device Co. Ltd.
• Micro Lab Instruments
• Zeal Medical
• Dragerwerk AG & Co. KGaA
• Labtron Equipment Ltd
• Korrida Medical Systems
• GPC Medical Ltd
• Braun & Co. Limited

第13章 付録

Overview

Global Bilirubin Meters Market reached US$ 108.1 million in 2023 and is expected to reach US$ 136.4 million by 2031, growing at a CAGR of 10.16% during the forecast period 2024-2031.

The bilirubin meter is a device that measures the amount of bilirubin in a patient's blood. It is an important tool in the diagnosis and treatment of neonatal jaundice. It typically uses spectrophotometric methods to measure bilirubin levels, which aids in the diagnosis and monitoring of illnesses like jaundice, liver disease, and hemolytic disorders.

Bilirubin meters can be found in both portable and laboratory settings, giving essential data for clinical decision-making. Commonly used in neonates to assess jaundice, determining its severity and the need for treatment, such as phototherapy. They help in evaluating and analyzing bilirubin metabolism and help in diagnosing liver diseases such as hepatitis, cirrhosis, and other metabolic diseases.

Market Dynamics: Drivers & Restraints

Technological advancement in bilirubin meters

Technological advancements in bilirubin meters are expected to drive the market growth. Enhanced measuring techniques, such as enhanced spectrophotometry and multi-wavelength analysis, produce more consistent results, boosting trust in these instruments. Non-invasive bilirubin meters, that utilize light sensors to monitor bilirubin levels via the skin are expected to improve the comfort and accessibility of screening, especially for babies.

Advances in miniaturization and user interface design have led to more portable, simple-to-use devices that can be operated by healthcare professionals with minimal instruction, allowing for widespread use. Faster analysis times improve workflow efficiency in clinical environments, allowing for rapid diagnostic and treatment decisions. Technological advancements can result in lower manufacturing costs, making bilirubin meters cheaper for healthcare facilities and boosting market share. Thus, the above factors are expected to drive the market growth.

High cost of the devices

Hospitals and clinics, particularly in low- and middle-income areas, may need help with funding costly equipment. This can limit their ability to invest in new technologies, impeding their adoption. If cheaper options exist, buyers in the future may choose them, making it difficult for high-priced products to compete. This could result in a lower market share for premium products.

Segment Analysis

The global bilirubin meters market is segmented based on product type, age group, indication, end-user, and region.

Transcutaneous segment is expected to dominate the market share

The transcutaneous segment holds a significant position in the global market share and is expected to continue throughout the forecast period. These gadgets are non-invasive, accurate, cost-effective, and time-saving.

Moreover, transcutaneous devices are used to screen jaundice in newborn babies without a needle prick, and they are becoming more popular as an alternative to serum bilirubin analyzers. Transcutaneous bilirubinometers serve as a valid screening method for identifying neonates who require total serum bilirubin measurement before phototherapy.

Transcutaneous meters produce immediate results, allowing for more rapid clinical decision-making and rapid action in situations like as jaundice. Due to their efficiency and portability, these devices are gaining demand and are expected to hold a significant position in the market share.

Geographical Analysis

North America is expected to hold a significant position in the bilirubin meters market share

North America accounted for the highest revenue share. The increasing prevalence of liver diseases, the rising geriatric population, rising healthcare spending, well-established infrastructure, and technological advancements in bilirubin meters are factors expected to boost the market in the forecast period.

For instance, according to the Children's Hospital of Philadelphia in 2024, it is stated that hyperbilirubinemia is very common, affecting approximately 60 percent of term newborns and 80 percent of premature babies develop jaundice. The increasing number of hyperbilirubinemias requires continuous evaluation and analysis of the quantity of bilirubin, thus increasing the demand for the devices. Thus, the above factors are expected to hold the region's market growth.

Market Segmentation

By Product Type

• Bench-top
• Transcutaneous

By Age Group

• Neonates
• Adults
• Others

By Indication

• Hepatitis
• Jaundice
• Others

By End-User

• Hospitals
• Clinics
• Diagnostic Centers
• Others

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Middle East and Africa

Competitive Landscape

The major global players in the market include Delta Medical International Ltd, Mennen Medical Ltd, Ningbo David Medical Device Co. Ltd., Micro Lab Instruments, Zeal Medical, Dragerwerk AG & Co. KGaA, Labtron Equipment Ltd, Korrida Medical Systems, GPC Medical Ltd and Braun & Co. Limited. among others.

Why Purchase the Report?

• To visualize the global bilirubin meters market segmentation based on product type, age group, indication, end-user, and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of bilirubin meters market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as Excel consisting of key products of all the major players.

The global bilirubin meters market report would provide approximately 53 tables, 47 figures, and 176 pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Product Type
• 3.2. Snippet by Age Group
• 3.3. Snippet by Indication
• 3.4. Snippet by End-User
• 3.5. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Technological advancement in bilirubin meters
  • 4.1.2. Restraints
    • 4.1.2.1. High cost of the devices
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. Reimbursement Analysis
• 5.6. Patent Analysis
• 5.7. SWOT Analysis
• 5.8. DMI Opinion

6. By Product Type

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 6.1.2. Market Attractiveness Index, By Product Type
• 6.2. Bench-top*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Transcutaneous

7. By Age Group

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
  • 7.1.2. Market Attractiveness Index, By Age Group
• 7.2. Neonates*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Adults
• 7.4. Others

8. By Indication

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
  • 8.1.2. Market Attractiveness Index, By Indication
• 8.2. Hepatitis*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Jaundice
• 8.4. Others

9. By End-User

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.1.2. Market Attractiveness Index, By End-User
• 9.2. Hospitals*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Clinics
• 9.4. Diagnostic Centers
• 9.5. Others

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
    • 10.2.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 10.2.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 10.2.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.2.3.1. The U.S.
    • 10.2.3.2. Canada
    • 10.2.3.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
    • 10.3.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 10.3.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
  • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.3.4.1. Germany
    • 10.3.4.2. UK
    • 10.3.4.3. France
    • 10.3.4.4. Italy
    • 10.3.4.5. Spain
    • 10.3.4.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
    • 10.4.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 10.4.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
  • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.4.4.1. Brazil
    • 10.4.4.2. Argentina
    • 10.4.4.3. Rest of South America
• 10.5. Asia-Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
    • 10.5.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 10.5.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
  • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.5.4.1. China
    • 10.5.4.2. India
    • 10.5.4.3. Japan
    • 10.5.4.4. South Korea
    • 10.5.4.5. Rest of Asia-Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
    • 10.6.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 10.6.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
  • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Market Positioning/Share Analysis
• 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

• 12.1. Delta Medical International Ltd*
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Financial Overview
  • 12.1.4. Key Developments
• 12.2. Mennen Medical Ltd
• 12.3. Ningbo David Medical Device Co. Ltd.
• 12.4. Micro Lab Instruments
• 12.5. Zeal Medical
• 12.6. Dragerwerk AG & Co. KGaA
• 12.7. Labtron Equipment Ltd
• 12.8. Korrida Medical Systems
• 12.9. GPC Medical Ltd
• 12.10. Braun & Co. Limited

LIST NOT EXHAUSTIVE

13. Appendix

• 13.1. About Us and Services
• 13.2. Contact Us